Frutos M A, Mansilla J J, Cabello M, Soler J, Ruiz P, Lebrón M, Baena V, Hernández D
Coordination Transplant Unit, Hospital Regional Universitario Carlos Haya de Málaga, Málaga, Spain.
Transplant Proc. 2012 Sep;44(7):2060-2. doi: 10.1016/j.transproceed.2012.07.076.
Cadaveric donation is now experiencing a trend toward the use of expanded criteria donors (ECD) who may not yield a suitable kidney for single organ transplantation which has occasionally led to their use as dual renal transplantations.
We undertook a case-control study to analyze our experiences between May 2007 and March 2011 with 80 kidneys from ECD who were older than 65 years. Of these, 40 were used as single transplants (STX) and the other 40 as dual cases (DTX). Criteria to determine STX versus DTX were established by biopsy results and other donor factors.
The mean age of the ECD for STX was 68.7 ± 3.0 years and for DTX, 74.2 ± 4.3 years (P < .001), with more women among DTX (75%) versus STX (40%; P < .001). The DTX kidneys showed higher biopsy scores than the STX organs. DTX were older than STX recipients, but there were no differences in cold ischemia time, delayed graft function, hemorrhagic complications or reinterventions. DTX recipients achieved better CrCl at 1, 3, 6, and 12 months, although only significantly so at 6 months (53.4 ± 19.5 Ml/min versus 44.5 ± 15.6 mL/min; P < .05). Death-censored graft survival was 90% at 3 years for both groups.
DTX offered good results for graft survival and renal function, despite the more complicated surgery and worse quality of the allografts. DTX allowed the use of ECD kidneys that showed less satisfactory histologic and donor characteristics.
尸体捐赠目前正呈现出一种趋势,即使用扩展标准供体(ECD),这些供体可能无法提供适合单器官移植的肾脏,这偶尔导致它们被用于双肾移植。
我们进行了一项病例对照研究,以分析2007年5月至2011年3月期间我们使用80个来自65岁以上ECD的肾脏的经验。其中,40个用于单肾移植(STX),另外40个用于双肾移植(DTX)。通过活检结果和其他供体因素确定STX与DTX的标准。
STX组ECD的平均年龄为68.7±3.0岁,DTX组为74.2±4.3岁(P<.001),DTX组女性比例更高(75%),而STX组为40%(P<.001)。DTX组的肾脏活检评分高于STX组。DTX组的受者年龄比STX组大,但在冷缺血时间、移植肾功能延迟、出血并发症或再次干预方面没有差异。DTX组受者在1、3、6和12个月时的肌酐清除率(CrCl)更好,尽管仅在6个月时显著更好(53.4±19.5毫升/分钟对44.5±15.6毫升/分钟;P<.05)。两组的3年死亡截尾移植存活率均为90%。
尽管手术更复杂且同种异体移植物质量更差,但双肾移植在移植存活和肾功能方面取得了良好结果。双肾移植允许使用组织学和供体特征不太理想的ECD肾脏。